Study of Neoadjuvant Myocet®, Paclitaxel, Pertuzumab, and Trastuzumab in HER2-positive Breast Cancer
Clinical trial NCT01669239 · COMPLETED
Trial details
- NCT number
- NCT01669239
- Sponsor
- SOLTI Breast Cancer Research Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2016-01-01
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.